Terril Brothers’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$161K Hold
16,600
– – 0.04% 80
2026
Q2
$193K Hold
16,600
– – 0.05% 70
2026
Q1
$279K Sell
16,600
-2,375
-13% -$42.5K 0.08% 64
2025
Q4
$304K Buy
+18,975
New +$282K 0.08% 54

Other funds holding CLB

Terril Brothers's CLB Position: Q3 2026 in Review

Terril Brothers held its Core Laboratories (CLB) position steady in Q3 2026 at 16,600 shares worth $161K. The position accounts for 0.04% of the portfolio, ranked #80.

Terril Brothers first reported a position in CLB in Q4 2025 and has held it in 4 quarters since. The position peaked at $304K in Q4 2025. 143 funds tracked by Wall St. Rank hold CLB as of Q3 2026.

  • Terril Brothers held 16,600 shares of Core Laboratories worth $161K as of Q3 2026.
  • Terril Brothers left its Core Laboratories share count unchanged in Q3 2026.
  • Core Laboratories made up 0.04% of Terril Brothers's portfolio in Q3 2026, its #80 holding.
  • Terril Brothers first reported a position in Core Laboratories in Q4 2025 and has held it in 4 quarters since.
  • Terril Brothers's Core Laboratories position peaked at $304K in Q4 2025.
  • 143 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.

Based on Terril Brothers's 13F filing for Q3 2026, filed 6 Nov 2026.